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Abstract
The regulation of neurite outgrowth is crucial in developing strategies to promote neurite regeneration after nerve injury
and in degenerative diseases. In this study, we demonstrate that overexpression of an adaptor/scaffolding protein SH2B1b
promotes neurite re-growth of differentiated PC12 cells, an established neuronal model, using wound healing (scraping)
assays. Cell migration and the subsequent remodeling are crucial determinants during neurite regeneration. We provide
evidence suggesting that overexpressing SH2B1b enhances protein kinase C (PKC)-dependent cell migration and
phosphatidylinositol 3-kinase (PI3K)-AKT-, mitogen activated protein kinase (MAPK)/extracellular signal-regulated protein
kinase (ERK) kinase (MEK)-ERK-dependent neurite re-growth. Our results further reveal a cross-talk between pathways
involving PKC and ERK1/2 in regulating neurite re-growth and cell migration. We conclude that temporal regulation of cell
migration and neurite outgrowth by SH2B1b contributes to the enhanced regeneration of differentiated PC12 cells.
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Introduction
Neuronal injury and degeneration are responsible for various
neurological diseases. The limited regeneration capacity restricts
the recovery of neuronal damage. Thus, better understanding of
the mechanisms for neuronal repair will facilitate clinical
application of therapy toward neurological disorders. Peripheral
nerve transection (axotomy) is often used as a neuronal injury
model. During regeneration of the peripheral nervous system
(PNS), cell body of the neurons must to receive appropriate signals
to sustain intrinsic growth to ensure successful regeneration. Thus,
the regulation of signaling cascades and downstream gene
expression often determines the regeneration outcome [1,2,3].
For instance, axonal injury induces local activation and retrograde
transport of extracellular signal-regulated protein kinase (ERK)
[4,5,6] and c-Jun N-terminal kinase (JNK) [7,8]. A study showed
that mitogen activated protein kinase (MAPK)/ERK kinase
(MEK) kinase 1 (MEKK1) controls neurite re-growth by balancing
ERK1/2 and JNK2 signaling after experimental injury [9]. These
studies suggest that activation of JNK and ERK and their
interaction with the dynein/dynactin retrograde molecular motors
is required for regeneration [1,5,7]. Moreover, overexpression of
constitutively activated AKT has been shown to protect motor
neurons from injury-induced cell death and thus promotes axonal
regeneration [10,11]. By intraperitoneally administrating vanadi-
um compounds to stimulate the activation of phosphatidylinositol
3-kinase (PI3K)-AKT and MEK-ERK1/2 pathways, neurogenesis
as well as newborn cells are increased in response to brain
ischemia [12].
Neurotrophic factors, including nerve growth factor (NGF),
fibroblast growth factor (FGF), glial cell -derived neurotrophic
factor (GDNF), brain-derived neurotrophic factor (BDNF),
neurotropin-3 (NT-3) and neurotropin-4/5 (NT-4/5), not only
regulate neuronal development, but also play positive roles in
enhancing regeneration [13,14]. Evidence demonstrates that NGF
promotes long distance axonal regeneration in cerulospinal axons
and primary sensory axons [15,16,17]. As NGF binds to its
receptor TrkA, trans-phosphorylation of the receptors leads to
their activation. The phosphorylated tyrosine residues can serve as
docking sites for signaling molecules within MEK-ERK, PI3K-
AKT, and phospholipase Cc (PLCc)-Protein kinase C (PKC)
pathways, to further transmit signals to downstream effectors [18].
Previous studies show that MEK-ERK pathway is essential for
NGF-induced neurite outgrowth in pheochromocytoma-derived
PC12 cell, an established neuronal model cell line [19,20,21].
Activation of PI3K-AKT, on the other hand, is required for the
protection of PC12 cells from apoptosis as well as for the
neuritogenesis of dorsal root ganglion (DRG) sensory neurons
[22,23,24]. Interestingly, both Ras-Raf-ERK and PI3K-AKT
pathways have been shown essential for NGF-induced axonal
growth of embryonic DRG neurons [25]. Ras-Raf-ERK cascade
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e34999
regulates the axon elongation whereas PI3K-AKT signaling
increases the axon caliber and branch [25]. These studies
implicate the importance of ERK1/2, JNK, and PI3K-AKT
pathways in neurite outgrowth.
Cell migration is instrumental for injury-induced neurogenesis
and tissue regeneration [26,27,28,29,30]. It has been shown that
progenitor cells from periventricular region proliferate and
migrate into the hippocampus to regenerate new neurons after
ischemia, thus reduce neurological deficits in vivo [31]. Evidence
Figure 1. Overexpression of SH2B1b enhances wound healing of differentiated PC12 cells. PC12-GFP, PC12-SH2B1b cells (A–D) and PC12-
GFP, PC12-SH2B1b, PC12-(D150–200), PC12-(D200–268) cells (F) were differentiated by 50 ng/ml NGF treatment for 8 days. On day 8, differentiated
cells were scraped by P10 tips and defined as healing day 0. Live cell images of the same wounded gaps were taken every 24 h for at least 7 days.
Representative images are shown. Scale bar: 200 mm. (E) The percentages of wound closure were quantified as described in the Materials and
Methods. Values are mean6 S.E.M. from seven independent experiments for healing days 0–7 and four independent experiments for healing days 8
and 9. (F) The percentages of wound closure on healing day 6 are show. Data are mean 6 S.E.M. from three independent experiments. (*: compared
to the percentages of PC12-GFP cells on the same day, P,0.05, paired Student’s t-test).
doi:10.1371/journal.pone.0034999.g001
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suggests that activities of PLC and PKC, and intracellular Ca2+
levels are important regulators of cell migration in the developing
brain [32]. PLC is the key enzyme which mediates the balance
between intracellular Ca2+ and cellular phosphoinositide. PLC
isozymes mainly localize in cytosol, and translocate to plasma
membrane, where PLC hydrolyzes phosphatidylinositol 4,5-
bisphosphate (PIP2) into inositol 1,4,5-trisphosphate (IP3) and
diacylglycerol (DAG), as stimulated by hormones or neurotrans-
mitters [33]. The produced second messenger IP3 increases
endoplasmic reticulum-released Ca2+ and DAG regulates the
activation of PKC. One of the PLC isozymes mainly regulated by
receptor and cytosolic tyrosine kinase is PLCc1 [34,35], which
expresses in lung, thymus, and highly expresses in neurons of adult
rat brain [36]. In addition to growth factors-mediated chemotaxis,
a study indicates that PLCc1 is an essential molecule for cell
motility in integrin signaling [37], suggesting the general role of
PLCc1 in cell motility. PKC isoforms are known to influence cell
morphogenesis by remodeling microfilaments [38]. They have also
been implicated in diverse signal propagation [39]. The ability of
neurons to respond to injury, integrate signals, and remodel actin
cytoskeleton determines the recovery outcome. Increasing evi-
dence suggests that protein scaffolds are involved in temporally
and spatially organizing signaling events to downstream transcrip-
tional activity and actin remodeling.
One such scaffolding protein, SH2B1, belongs to the SH2B
adaptor protein family [40,41]. SH2B1b (b splice variant) has been
shown to bind to multiple receptor tyrosine kinases, including
receptors for NGF, FGF, and GDNF [42,43,44,45,46,47]. SH2B1
is necessary for survival of sympathetic neurons [45]. It positively
regulates the Akt/Forkhead pathway and has recently been shown
to reduce oxidative stress-induced cell death in PC12 cells,
hippocampal neurons and Drosophila [22,48,49]. Overexpressing
SH2B1b also enhances both NGF-, FGF1- and GDNF-induced
neuronal differentiation of PC12 cells [42,43,44,45]. Given its
ability to promote neurite outgrowth and survival, we hypothesize
that SH2B1b may play a positive role in neuronal regeneration.
This study investigated the role of SH2B1b in the regeneration of
injured differentiated PC12 cells.
Materials and Methods
Reagents
Anti-ERK1/2 antibody and phorbol 12-myristate 13 acetate
(PMA or TPA) were obtained from Sigma (S. Louis, MO). Anti-
pPLCc1(Tyr783), pSrc(Tyr416) family antibodies and horseradish
peroxidase (HRP)-conjugated goat anti-mouse IgG were obtained
from Cell Signaling (Danvers, MA). Anti-pERK1/2(Thr202,
Tyr204) was purchased from Bioworld (Minneapolis, MN). Anti-
Histone deacetylases (HDAC) and PLCc1 antibodies were
obtained from Millipore (Billerica, MA). Neuronal class III b-
tubulin (Tuj1) was obtained from Covance (Richmond, CA).
Alexa-Flour 555-conjugated goat anti-mouse antibody was
obtained from Invitrogen (Carlsbad, CA). NGF and rat-tail
collagen I were purchased from BD Bioscience (Bedford, MA).
Protein Assay Kit (PAK500) was purchased from Strong Biotech
Corporation, Taiwan. BCA assay reagent was purchased from
SantaCruz Biotechnology (Santa Cruz, CA). IRDye800CW-
labeled anti-rabbit secondary antibody was purchased from LI-
COR Biosciences (Lincoln, NE). CFTM680 goat anti-mouse IgG
was purchased from Biotium, Inc (Hayward, CA). U0126,
LY294002 and Bisindolyleimide I hydrochloride (Bis) were
purchased from Calbiochem (San Diego, CA).
Cell culture and stable cell lines
The stock of PC12 cells was purchased from American Type
Culture Collection. PC12 cells were maintained on the collagen-
coated plates (coated with 0.16–0.2 mg/ml rat-tail collagen in
0.02 N acetic acid) and grown at 37uC in 10% CO2 in complete
media, DMEM supplemented with 10% horse serum (HS), 5%
fetal bovine serum (FBS), 1 mM L-glutamine and 1 mM
antibiotic-antimycotic (Invitrogen). PC12 cells stably overexpress-
ing GFP (PC12-GFP) or GFP-SH2B1b (PC12-SH2B1b) were
made and cultured as described in Lin et al [42]. PC12 stable cell
lines that express GFP-SH2B1b(D150–200) [PC12-(D150–200)]
and GFP-SH2B1b(D200–268) [PC12-(D200–268)] were made for
this study. A pooled population of stable clones was used to avoid
clonal variation. During differentiation, cells were cultured in a
differentiation medium (DMEM supplemented with 1% HS)
containing NGF.
Neuronal injury experiments and cell migration tracking
For wound healing assays, cells were seeded on collagen-coated
plates at 30% confluency and differentiated using NGF (50 ng/ml)
for 8 days. The medium was changed every other day. The
definition of neuronal differentiation for PC12 cells is that the
length of neurites is at least twice the diameter of the cell body. On
day 8, cells were wounded by scraping cells with a P10 pipette tip.
Live cell images of cells were taken everyday using an inverted
Zeiss Axiover 135 fluorescence microscope or the Carl Zeiss
Observer Z1. The averaged width of the wounded gaps was
measured from 12 different locations per wounded gap per time
point (also see Figure S1). At least 6 wounded gaps were quantified
from three independent experiments. The width of the remaining
wounded gaps was averaged and divided by the width of initial
wounded gaps. The percentage of wound closure was calculated as
(100%- remaining wounded gaps%). The tracking function of
AxioVision software (Zeiss) was used to track cell migration of a
specific group of cells. For each wound healing experiment, at least
8 groups of cells per field were tracked for each time point.
Position of cells was imaged and the net cell migration every 24 h
was calculated for at least 6 days. Accumulated distance is the total
distance that cells migrate over time (0–144 h). Cell motility is
defined as the accumulated distance/time.
For re-plating experiments, PC12-GFP and PC12-SH2B1b cells
were seeded on 10-cm collagen-coated plates at 30% confluency
and differentiated with NGF (50 ng/ml). On day 8, cells were
rinsed using 16 PBS three times, trypsinization, and centrifuged
(2356g, 1 min at RT). Cells were re-suspended by pipetting up
and down to remove the neurites, and then re-plated cells in
25 ng/ml NGF-containing differentiation medium. To examine
neurite re-growth of differentiated PC12 cells, live cell images of
random fields of at least 80 re-plated cells were taken using Carl
Zeiss Observer Z1 microscope. The percentage of differentiated
cells is defined as the numbers of cells with neurite length at least
twice the diameter of cell bodies divided by the numbers of total
cells counted.
Immunoblotting and immunoprecipitation
Cells were harvested into RIPA (50 mM Tris, pH 7.5, 1%
Triton X-100, 150 mM NaCl, 2 mM EGTA) containing 1 mM
Na3VO4, 1 mM phenylmethanesulphonylfluoride (PMSF),
10 ng/ml aprotinin and 10 ng/ml leupeptin. Protein concentra-
tion of each sample was determined. Equal amounts of proteins
were loaded to and resolved by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE), followed by
western blotting analysis using the indicated antibodies. For
immunoprecipitation of PKC, cells were lysed in RIPA buffer
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containing 1 mM Na3VO4, 1 mM PMSF, 10 ng/ml aprotinin
and 10 ng/ml leupeptin. Cell lysates were incubated with
monoclonal PKC antibodies (1:200) overnight at 4uC. Immuno-
precipitated proteins were subjected to SDS-PAGE and Western
blotting. The immunoblots were detected using either IRDye-
conjugated IgG and the Odyssey Infrared Imaging System (LI-
Figure 2. Overexpression of SH2B1b promotes pERK1/2-dependent neurite re-growth of differentiated PC12 cells after injury. (A)
PC12-GFP and PC12-SH2B1b cells were differentiated as in Figure 1. On day 8, differentiated cells were trypsinized and neurites were removed via
pippeting up and down. Live cell images of re-plated cells were taken over time. Representative images are shown. Scale bar: 20 mm. (B) Percentages
of differentiated cells were determined as described in the Materials and Methods. Values are mean 6 S.E.M. from four independent experiments. (*:
P,0.05, paired Student’s t-test) (C) PC12-GFP and PC12-SH2B1b cells were differentiated as in Figure 1. On day 8, cells were pre-treated with DMSO
(Mock) or 20 mM U0126 for 1 h before wounding. Cell lysates were extracted on healing day 12 and resolved via SDS-PAGE followed by
immunoblotting using antibodies against pERK1/2 and ERK1/2. (D) Percentages of wound closure were determined as in Figure 1. Values are mean6
S.E.M from at least three independent experiments. (*: P,0.05, paired Student’s t-test).
doi:10.1371/journal.pone.0034999.g002
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COR Biosciences) or the horseradish peroxidase-conjugated IgG
and ECL system.
Immunofluorescence staining
Cells were seeded on the collagen-coated plates at 30%
confluency and differentiated with 50 ng/ml NGF in the
differentiation medium for 8 days. On day 8, cells were wounded
by a P10 pipette tip and fixed by 4% paraformaldehyde,
permeabilized, and incubated with anti-neuronal tubulin antibod-
ies, followed by incubation with the Alexa Fluor 555-conjugated
secondary antibody for visualization. DAPI staining was used to
visualize the nucleus. Images were taken by an upright fluorescent
microscope Zeiss/Axioskop 2 mot plus and the Carl Zeiss
Observer Z1.
Inhibitor and activator assays
Cells were seeded on the collagen-coated 6-well plates at 30%
confluency and differentiated with 50 ng/ml NGF in the
differentiation medium for 8 days. On day 8, cells were pretreated
with DMSO (Mock), 20 mM U0126, 20 mM LY294002 or 0.1–
2.5 mM Bis for 1 h before wounding. Images were taken by the
Carl Zeiss Observer Z1. For the PKC activation assay, wounded
cells were treated with 162 nM PMA or DMSO (Mock). Images of
cells were taken using the inverted Zeiss Axiover 135 fluorescence
microscope or the Carl Zeiss Observer Z1. Images of wounded
cells were tracked using the tracking function of Axio Vision
software (Zeiss).
Statistical analysis
Most of the comparisons were determined using paired
Student’s t-test or one-way ANOVA. Significant difference is
defined as P value less than 0.05.
Results
Overexpression of SH2B1b promotes wound healing of
differentiated PC12 cells
To determine the role of SH2B1b in neurite regeneration, two
stable cell lines, PC12 cells stably expressing GFP (PC12-GFP) and
PC12 cells stably expressing GFP-SH2B1b (PC12-SH2B1b), were
established [42]. Wound healing (scraping) assays were performed
to recapitulate injury and recovery. These two stable cell lines
were differentiated into neurons by NGF (50 ng/ml) treatment for
8 days. On day 8, cells were subjected to mechanical scraping
(Figure 1A and C). Differentiated PC12 cells depend on NGF for
maintaining neuronal status. Thus, NGF was present at all time
during healing (regeneration). The percentage of wound closure
during healing was measured as described in the Materials and
Methods, and in Figure S1. After healing for 5 days, differentiated
PC12-SH2B1b cells healed better than PC12-GFP cells (Figure 1B
and D). The quantified results revealed that the percentages of
wound closure were higher for differentiated PC12-SH2B1b cells
compared to those for PC12-GFP cells after healing day 4
(Figure 1E). On healing day 5, wound closure was 70% for
differentiated PC12-GFP cells whereas it was 85% for differenti-
ated PC12-SH2B1b cells. The percentage of wound closure for
differentiated PC12-SH2B1b cells continued to increase over time
while the healing rate was slower for PC12-GFP cells. To verify
that the enhanced percentage of wound closure is SH2B1-
dependent, knocking down SH2B1 seems to be the best approach
to address the question. However, knocking down SH2B1
significantly reduces neuronal differentiation. Thus, two loss-of-
function mutants of SH2B1b, SH2B1b(D150–200) and
SH2B1b(D200–268), were used to examine the effect on neurite
regeneration. SH2B1b(D150–200) lacks nuclear localizing se-
quences whereas SH2B1b(D200–268) lacks nuclear export signal.
As shown in Figure 1F, PC12 cells stably expressing
SH2B1b(D150–200) or SH2B1b(D200–268) reduced % of wound
closure compared to cells expressing SH2B1b. These results
suggest that the enhanced regeneration is SH2B1b-dependent.
Notably, the wounded gaps were filled with neurites and a few cell
bodies (Figure 1B and D). These results implicate the involvement
of neurite re-growth and cell migration during the healing process.
In addition, SH2B1b may promote neurite re-growth and/or cell
migration during neuronal regeneration.
Overexpression of SH2B1b promotes MEK-ERK1/2- and
PI3K-AKT-dependent neurite re-growth
To examine whether SH2B1b could promote neurite re-
growth, cell re-plating experiments were performed on the
differentiated PC12 cells. PC12-GFP and PC12-SH2B1b cells
were differentiated, trypsinized to detach cells, pipetted up and
down to remove neurites and then re-plated. Neurite re-growth
was monitored over time. As shown in Figure 2A, all neurites were
removed after trypsinization. Neurite re-growth occurred as early
as 2 h after re-plating. The percentages of differentiated cells
(defined in the Materials and Methods) for PC12-SH2B1b cells at
6 and 24 h after re-plating were around 3.5- and 1.8-fold of those
for PC12-GFP cells respectively (Figure 2B). Together with results
from Figure 1, overexpression of SH2B1b enhances neurite re-
growth in response to injury.
To determine what signaling molecules are involved in
SH2B1b-mediated neurite re-growth, activity of MEK-ERK1/2
and PI3K-AKT pathways during neuronal regeneration were
examined. PC12-GFP and PC12-SH2B1b cells were differentiated
for 8 days and then pre-treated with U0126 (MEK inhibitor) or
LY294002 (PI3K inhibitor) for 1 h before wounding. In the
present of U0126, the phosphorylation of ERK1/2 was inhibited
(Figure 2C). The percentages of wound closure were reduced 70–
85% for PC21-GFP cells and 58–86% for PC12-SH2B1b cells in
the presence of U0126 (Figure 2D). These results suggest that
ERK1/2 activity is essential for neurite re-growth as well as
SH2B1b-mediated functions.
PI3K-AKT pathway contributes to both cell survival and
neurite outgrowth [11,23,50]. The effects of inhibiting phosphor-
ylated AKT during wound healing were also examined. Tuj1
staining results showed that neurite re-growth was better for
differentiated PC12-SH2B1b cells compared to PC12-GFP cells
on healing day 7. In addition, LY294002 treatment reduced
neurite re-growth (Figure 3A). Similar with the inhibition of
pERK1/2, neurite re-growth was reduced 37 to 77% in the
present of LY294002 for both cell lines (Figure 3B). These results
demonstrated that both MEK-ERK1/2 and PI3K-AKT pathways
Figure 3. AKT-dependent neurite re-growth during wound healing of PC12 cells. PC12-GFP and PC12-SH2B1b cells were differentiated as
in Figure 1. On day 8, differentiated cells were pretreated with DMSO (Mock) or 20 mM LY294002 for 1 h before wounding. (A) PC12-GFP and PC12-
SH2B1b cells were fixed on healing day 7. Neuronal tubulin staining was determined using anti-Tuj1 antibody followed by Alexa Fluor 555 (red). DAPI
(blue) staining showed the location of the nucleus. Scale bar: 50 mm. (B) Percentages of wound closure were determined as in Figure 1. Values are
mean 6 S.E.M. from four independent experiments. (*: P,0.05, paired Student’s t-test).
doi:10.1371/journal.pone.0034999.g003
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are required for SH2B1b-mediated enhancement of neurite re-
growth.
Overexpression of SH2B1b correlates with enhanced cell
migration and elevated phosphorylation of PLCc1 and
PKC
In addition to regenerated neurites, cell bodies also appeared in
the wounded gaps for both PC12-GFP and PC12-SH2B1b cells on
healing day 5, indicative of cell migration to the wounded gaps
(Figure 1B and D). We thus examined whether overexpression of
SH2B1b would enhance cell migration to promote regeneration.
PC12-GFP and PC12-SH2B1b cells were differentiated and
subjected to wound healing protocol. Migration of cells from
healing time 0 (blue color) to 144 h (red color) were tracked and
analyzed (Figure 4A). During 6 days of healing, the accumulated
distance that PC12-SH2B1b cells migrated was 170 mm in
average, compared to 90 mm by PC12-GFP cells (Figure 4B, left
panel), suggesting that their motility was higher (Figure 4B, right
panel). Based on the known effects of PKC on cell motility, we
next examined whether SH2B1b increases cell migration through
PLCc and/or PKC. To this end, cell lysates were collected from
differentiated PC12-GFP and PC12-SH2B1b cells before wound-
ing (U) and during healing days 0–5. Phosphorylation of PLCc1
was determined via western blotting. The overall phosphorylation
levels of PLCc1 in differentiated PC12-SH2B1b cells were around
1.4- to 3.1-fold of those in PC12-GFP cells. In addition, the levels
of pPLCc1 were reduced on healing day 5 (Figure 4C–D). The
phosphorylation of PKC, a downstream effector of PLCc1, was
also examined. Total PKC was immunoprecipitated and its
phosphorylation level was determined. The relative PKC
phosphorylations at serine and threonine residues for differenti-
ated PC12-SH2B1b cells were around 1.7- and 2.6-fold of those in
PC12-GFP cells respectively (Figure 4E). These results are
consistent with our hypothesis that SH2B1b promotes cell
migration through PLCc-PKC pathway. To determine whether
the enhanced cell migration is SH2B1-dependent, cell migration
after scraping injury was determined using PC12-(D150–200) and
PC12-(D200–268) cells that express two loss-of-function mutants of
SH2B1b. Cell migration for PC12-(D150–200) and PC12-(D200–
268) cells during healing was reduced compared to PC12-SH2B1b
cells and comparable to control PC12-GFP cells (Figure 5). Along
this line, cell migration for PC12-SH2B1b cells was reduced
around 20% by 1 mM PKC inhibitor, Bisindolyleimide I (Bis)
(Figure 6). Dose-dependent inhibition of cell migration by 0–
2.5 mM Bis was determined (Figure S2). To reduce the possibility
that inhibiting PKC may affect normal physiology of neuron cells,
low dosage of 1 mM Bis was used for this study. The fact that cell
migration of PC12-GFP cells was not inhibited by 1 mM Bis could
be due to lower motility or PKC activity in PC12-GFP cells
Figure 4. Increased cell migration of PC12-SH2B1b cells during
wound healing associates with elevated pPLCc1 and pPKC.
PC12-GFP and PC12-SH2B1b cells were differentiated and subjected to
wound healing as described in Figure 1. (A) Movement of cells around
the wounded gaps was tracked as described in the Materials and
Methods during healing for 6 days. The color lines represent the
migration path of cells from time 0 (blue) to 144 h (red) during healing.
(B) The accumulated distances and motility during time 0–144 h were
calculated. Cell motility (rate of cell migration) is defined as
accumulated distance/time. Values are mean 6 S.E.M. from four
independent experiments. (*: P,0.05, paired Student’s t-test) (C) Equal
amount of proteins from the harvested cell lysate of un-wounded (U) or
wounded cells was resolved via SDS-PAGE and immunoblotted with
anti-pPLCc1 and anti-PLCc1 antibodies. (D) Relative levels of pPLCc1
were normalized to total PLCc1 and then the levels in PC12-GFP cells on
differentiated day 8 (U). Values are mean 6 S.E.M. from at least three
independent experiments. (*: P,0.05, one-way ANOVA) (E) Lysate or
immunoprecipitated PKC were resolved via SDS-PAGE and immuno-
blotted with anti-PKC, pSer or pThr antibody. Relative pSer or pThr
levels were normalized to immunoprecipitated PKC and then the levels
in PC12-GFP cells on differentiated day 8 (un-wounded). Values are
mean 6 S.E.M. from three independent experiments for relative pSer
levels and mean 6 S.D. from two independent experiments for relative
pThr levels.
doi:10.1371/journal.pone.0034999.g004
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(Figure 4). Together, these results implicate that PLCc-PKC
pathway is involved in SH2B1b-mediated cell migration.
PKC activation promotes SH2B1b-enhanced cell
migration
Since PKC activity is involved in SH2B1b-enhanced cell
migration during wound healing, we next determined whether
activation of PKC contributes to SH2B1b-mediated migration.
Differentiated PC12-GFP and PC12-SH2B1b cells were wounded,
mock-treated or treated with PKC activator – phorbol 12-
myristate 13-acetate (PMA), and the effect on cell migration was
assessed. PMA activates PKC because of its similar structure to
DAG. The distance PC12-SH2B1b cells migrated was around 2-
fold of that by PC12-GFP cells in mock-treated conditions
(Figure 7). PMA treatment significantly enhanced cell migration
Figure 5. Overexpression of SH2B1b mutants reduce cell migration. PC12-GFP, PC12-SH2B1b, PC12-(D150–200) and PC12-(D200–268) cells
were differentiated and subjected to wound healing as described in Figure 1. (A) Movement of cells around the wounded gaps was tracked as
described in the Materials and Methods for 6 days during healing. The color lines represent the migration path of cells from time 0 (blue) to 144 h
(red) during healing. (B) The accumulated distances and motility during time 0–144 h were calculated. Cell motility is defined as accumulated
distance/time. Values are mean 6 S.E.M. from three independent experiments. (*: P,0.05, paired Student’s t-test).
doi:10.1371/journal.pone.0034999.g005
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of PC12-SH2B1b cells after healing for 6 days (Figure 7). The fact
that PMA stimulation promoted obvious cell migration for PC12-
SH2B1b cells but not so much for PC12-GFP cells suggests that
overexpression of SH2B1b may recruit PMA substrates closer to
plasma membrane where PMA acts. To confirm that the
activation of PKC was induced after the treatment of PMA, the
differentiated PC12-GFP and PC12-SH2B1b cells were treated
with or without PMA. Relative phosphoserine (pSer) of PKC was
increased approximately 60% after 6 h of PMA treatment for
PC12-GFP but not for PC12-SH2B1b cells (Figure S3). Relative
phosphothreonine (pThr) of PKC, on the other hand, was induced
1.1- to 3.4-fold for both cell lines (Figure S3). PMA-induced PKC
phosphorylation peaked at 6 h and then reduced by 24 h.
Consistent with the results in Figure 4E, basal phosphorylation
of PKC was higher in PC12-SH2B1b cells compared to PC12-
GFP cells. Interestingly, PMA treatment also increased the
expression of PKC. The increased PKC levels in differentiated
PC12-SH2B1b cells were 1.3- to 1.6-fold of those in PC12-GFP
cells (Figure S3). This may explain why the relative phosphory-
lation of PKC (after normalized to total PKC levels) in response to
PMA stimulation was not higher for PC12-SH2B1b cells
(Figure S3). A study showed that PMA promoted degradation of
PKC in human osteosarcoma cells [51]. However, it was not clear
which isozyme was referred to. Our data suggested that PMA
promoted degradation of PKCd (data not shown) but increased
synthesis of pan-PKCs (Figure S3). Thus, PMA-increased expres-
sion and phosphorylation of PKC likely account for the increased
cell migration of PC12-SH2B1b cells.
Fine balance between cell migration and neurite re-
growth warrants better wound healing
As PMA treatment promotes cell migration during wound
healing, it unexpectedly interfered with wound closure. Treatment
of PMA reduced 10% wound closure for differentiated PC12-GFP
cells and 25% for differentiated PC12-SH2B1b cells (Figure 8A).
This result raises a possibility that high motility of cells may
impede neurite outgrowth. Because neurite re-growth is largely
dependent on pERK1/2 (Figure 2), we thus examine whether
Figure 6. Inhibiting PKC activity decreases cell migration in PC12-SH2B1b cells. PC12-GFP and PC12-SH2B1b cells were differentiated as in
Figure 1. On day 8, differentiated cells were pre-treated with or without 1 mM Bis for 1 h before wounding. (A–D) Migration paths were tracked from
healing time 0 (blue) to 144 h (red) by tracking software. (E) Accumulated distance during healing days 0–6 for these cells were determined and
shown. Values are mean 6 S.E.M. from three independent experiments. (*: P,0.05, paired Student’s t-test).
doi:10.1371/journal.pone.0034999.g006
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pERK1/2 levels would be affected by PMA treatment. Cell lysates
were collected from differentiated cells before wounding (U) and
during healing days 0–5. Phosphorylation of ERK1/2 was
examined via western blotting. As shown in Figure 8B–C,
pERK1/2 levels were significantly reduced after the treatment
of PMA for both PC12-GFP and PC12-SH2B1b cells. The down-
regulation of pERK1/2 levels likely contributes to the reduced
neurite re-growth and wound healing. This result also reveals an
antagonistic role of cell motility and neurite outgrowth. As cell
migration is enhanced by PMA treatment, neurite re-growth is
reduced. If this is true, higher cell motility of PC12-SH2B1b cells
may not accompany with better neurite re-growth. Taking a closer
look at cell migration each day for both cell lines, cell motility for
PC12-SH2B1b cells was higher during healing days 0–4 and
reduced after healing day 4 (Figure 9A, left panel). Cell migration
during healing day 7–8 was also reduced compared to healing
day 0–1 for PC12-SH2B1b cells (Figure 9A, right panel). On the
other hand, pERK1/2 levels were lower for un-wounded PC12-
SH2B1b cells compared to PC12-GFP cells (Figure 9B, left panel),
whereas they were higher on healing day 7 (Figure 9B, right
panel). The reverse correlation between cell migration and
pERK1/2 suggests that overexpression of SH2B1b significantly
promoted cell migration toward wounded area before healing
day 4 and the neurite outgrowth after healing day 4. These results
Figure 7. PMA increases SH2B1b-enhanced cell migration during wound healing. PC12-GFP and PC12-SH2B1b cells were differentiated as
in Figure 1. On day 8, cells were wounded, treated without or with 162 nM PMA and allowed to heal for 6 days. (A) Live cell images were taken using
the inverted Zeiss Axiover 135 fluorescence microscope or the Carl Zeiss Observer Z1. Representative images are shown from three independent
experiments. (B) Migration paths were tracked from healing time 0 (blue) to 144 h (red) by tracking software every 24 h. (C) Accumulated distance
during healing days 0–6 were determined and shown. Values are mean6 S.E.M. from three independent experiments. (*: P,0.05, paired Student’s t-
test).
doi:10.1371/journal.pone.0034999.g007
SH2B1 Promotes Neurite Regeneration
PLoS ONE | www.plosone.org 10 April 2012 | Volume 7 | Issue 4 | e34999
suggest that a fine balance between cell motility and neurite re-
growth warrants better healing.
Together, results from this study demonstrated that overexpres-
sion of SH2B1b promoted regeneration of differentiated PC12 cells,
in response to scraping injury, after healing day 4. Rate of SH2B1b-
enhanced cell migration was faster during healing days 0–4 and
pERK1/2-mediated neurite re-growth was increased after healing
day 4. The fact that activated PKC increased cell migration but
reduced neurite re-growth suggests that cell migration and neurite
re-growth do not occur concomitantly during regeneration.
Discussion
In this study, we demonstrated that overexpression of a
signaling adaptor protein SH2B1b promotes neurite regeneration
of differentiated PC12 cells. During neurite regeneration,
overexpression of SH2B1b increases both cell motility and neurite
re-growth (Figures 1, 2 and 4). Neurite re-growth is significantly
blocked in the presence of MEK or PI3K inhibitor for both PC12-
GFP and PC12-SH2B1b cells (Figures 2 and 3). No obvious effect
on cell migration was found in the presence of these two inhibitors.
These results are in line with published results that both ERK1/2
and AKT contribute to neurite outgrowth [10,25].
Accumulating evidence from behavior, genetic and pharmaco-
logical studies have implicated PKC in an array of neuronal
functions, including release of neurotransmitters, synaptic func-
tions, learning and memory processes [52,53,54]. However, the
effect of PKC activation on neurite outgrowth has been
controversial. For example, PKC inhibitors have been reported
Figure 8. PMA treatment reduces wound closure and pERK1/2. PC12-GFP and PC12-SH2B1b cells were differentiated as in Figure 1. (A) On
day 8, differentiated cells were wounded and treated with DMSO (Mock) or 162 nM PMA. Percentages of wound closure on healing day 5 were
determined as described in the Materials and Methods. Values are mean 6 S.E.M. from three independent experiments. (*: P,0.05, Student’s t-test)
(B) On day 8, un-wounded (U) or wounded cells were treated with or without 162 nM PMA. Cell lysates were collected from un-wounded (U) cells and
cells during healing days 0–5. Equal amount of proteins from lysates was resolved via SDS-PAGE and immunoblotted with anti-pERK1/2 and anti-
ERK1/2 antibodies. (C) Relative pERK1/2 levels with or without PMA treatment were normalized to total ERK1/2 and then the levels of those on
differentiated day 8. Values are mean 6 S.E.M. from at least three independent experiments. (*: compared to the levels in no PMA-treated PC12-GFP
cells on differentiated day 8;#: compared to the levels in no PMA-treated PC12-SH2B1b cells on differentiated day 8, P,0.05, paired Student’s t-test).
doi:10.1371/journal.pone.0034999.g008
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to block neurite outgrowth in retinal axons, dorsal root ganglion
neurons, sympathetic neurons, PC12 cells, and hippocampal
cultures [55,56,57,58,59]. PKC inhibitors have also been shown to
promote dendritic growth of Purkinjie cells in cerebellar slice
cultures and to extend filopodia in DRG [60,61]. The addition of
dopamine causes neurite retraction of retinal neurons via
activating PKC, and eicosanoid activation of PKC also serves as
growth cone repellent signaling [62,63]. The discrepancy of these
results could simply be due to various types of neurons from
peripheral or central nervous systems. Alternatively, as suggested
in this study, temporal and possibly spatial control of PKC activity
during wound healing lead to diverse cell fates or healing
outcomes. Through inhibitor and activator assays, we further
demonstrated that PLCc-PKC pathway was involved in SH2B1b-
enhanced cell migration (Figures 6–7). Although PMA is a well-
known activator of PKC, Src has been suggested to be one of the
downstream targets and has been implicated in cell migration
[64,65,66]. To address this possibility, Src phosphorylation (pSrc)
with or without PMA treatment was investigated. As shown in
Figure S4, with PMA treatment, levels of pSrc were significantly
increased around 55 and 67% for PC12-GFP cells on healing
days 1 and 4, respectively. However, cell migration of PC12-GFP
cells was not significantly affected by PMA (Figure 7C). For PC12-
SH2B1b cells, pSrc was significantly increased by PMA only on
healing day 5 (Figure S4). However, PMA treatment increased
migration of PC12-SH2B1b cells before healing day 5 (Figure 7).
Thus, it seems unlikely that PMA stimulates SH2B1b-mediated
cell migration through increasing pSrc.
We found that cell motility was reversely correlated with
pERK1/2-dependent neurite re-growth. After healing day 4, cell
motility was reduced for PC12-SH2B1b cells whereas the wound
closure was better (Figures 1 and 9). Nonetheless, cell motility is
not necessary further reduced afterwards because, at a later
healing stage – healing day 23, more cell bodies were found at
wounded gaps suggesting another phase of increased cell
migration (Figure S5). Thus, we think that as both cell migration
and neurite re-growth contribute to neuronal regeneration, these
processes may occur in a pulsatile manner. An intriguing question
raised here is what signals cell to reduce or increase cell migration.
We found that PMA treatment increased the levels of SH2B1b
(Figure S6), phosphorylation of PKC (Figure S3), and cell
migration (Figure 7). Although SH2B1b has predicted PKC
phosphorylation site, exactly how PKC activity and SH2B1b
regulate each other during neuronal regeneration and whether
putative regulators are involved remain to be elucidated.
Evidence suggests that injury can induce stem cells migrating to
the injured sites to aid wound healing [67,68,69,70]. Thus,
promoting migration of neural stem cells or neural progenitor cells
to injured sites can enhance regeneration. As we demonstrated
that overexpression of SH2B1b promoted cell migration, we
Figure 9. Motility of cells overexpressing SH2B1b is higher during healing days 0–4 and reduced during healing days 5–8. PC12-GFP
and PC12-SH2B1b cells were differentiated and subjected to wound healing as described in Figure 1. (A) Cell migration was tracked every day and the
net distance per day was calculated. Values are mean 6 S.E.M. from four independent experiments for healing days 0–6 (left panel) and three
independent experiments for healing days 0–1 and 7–8 (right panel). (*: P,0.05, paired Student’s t-test) (B) Relative pERK1/2 levels were normalized
to total ERK1/2 and then the levels in PC12-GFP cells on differentiated day 8 (Un-wounded) or on healing day 7. Values are mean 6 S.E.M. from
eighteen independent experiments for un-wounded cells and four independent experiments for healing day 7. (*: P,0.05, paired Student’s t-test) (C)
SH2B1b modulates PKC-dependent cell migration and ERK1/2-mediated neurite re-growth depending on the healing stages. PKC-dependent cell
migration antagonizes ERK1/2-mediated neurite re-growth, and fine temporal regulation of cell migration and neurite re-growth contributes to the
optimal healing outcome.
doi:10.1371/journal.pone.0034999.g009
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cannot discern whether SH2B1b promotes differentiation of PC12
cells and then their migration to the wounded area, or SH2B1b
promotes cell migration to the wounded area and then enhances
their differentiation. Unfortunately, it is difficult to track
undifferentiated cells from a distance to the wounded area in
our system.
The current study reveals a novel function of SH2B1b in
promoting neuronal regeneration. MEK-ERK1/2 and PI3K-
AKT pathways are necessary for SH2B1b-mediated neurite re-
growth during wound healing. Increased SH2B1b level associates
with elevated phosphorylation of PLCc and PKC, and thus
promotes cell migration during regeneration. We further demon-
strate that a cross-talk between PKC and ERK1/2 pathways
contributes to temporal regulation of cell migration, neurite re-
growth and thus the outcome of regeneration.
Supporting Information
Figure S1 The quantification of wound closure. Distances
of at least 12 different locations within each wounded gap were
measured. The percentages of remaining wounded gaps were
calculated by averaged width of the wounded gap per time point
divided by the wounded gap on healing day 0. The percentage of
wound closure was defined as 100%- remaining wounded gaps%.
(DOC)
Figure S2 Dose-dependent inhibition of cell migration
by PKC inhibition. PC12-GFP and PC12-SH2B1b cells were
differentiated as in Figure 1. On day 8, differentiated cells were
pre-treated with or without 1 mM or 2.5 mM Bis for 1 h before
wounding. Accumulated distance during healing days 0–6 and net
distance between healing days 0 and 6 of cell migration were
determined and shown. Values are mean 6 S.E.M. from four
independent experiments for control cells and mean 6 S.D. from
two independent experiments for Bis-treated cells. (*: P,0.05
paired Student’s t-test).
(DOC)
Figure S3 Overexpression of SH2B1b enhances PMA-
induced PKC phosphorylation and synthesis. PC12-GFP
and PC12-SH2B1b cells were differentiated. On day 8, differen-
tiated cells were treated with or without 162 nM PMA and
harvested on indicating time points. Total lysates or immunopre-
cipitated PKCs were resolved via SDS-PAGE and immunoblotted
with anti-PKC, pSer, pThr or ERK1/2 antibody. Relative pSer or
pThr levels were normalized to the amount of immunoprecipitat-
ed PKC and then the levels in PC12-GFP cells on differentiated
day 8 (time 0 h). Relative PKC levels of cell lysates were
normalized to ERK1/2 and then the level in PC12-GFP cells
on differentiated day 8 (time 0 h).
(DOC)
Figure S4 Src may participate in PMA-mediated cell
migration of PC12 cells. PC12-GFP and PC12-SH2B1b cells
were differentiated and subjected to wound healing as described in
Figure 1. (A) Equal amount of proteins from the lysates of un-
wounded (U) or cells during healing days 0–5 was resolved via
SDS-PAGE and immunoblotted with anti-pSrc(Y416) and anti-
Src antibodies. (B) Relative levels of pSrc were normalized to total
Src and then the levels in PC12-GFP cells on differentiated day 8
(U). Values are mean 6 S.E.M. from at least three independent
experiments. (*: P,0.05, one-way ANOVA) (C) Relative levels of
pSrc were normalized to total Src and then the levels in PC12-
GFP cells on healing day 7. Values are mean 6 S.E.M. from five
independent experiments. (*: P,0.05, paired Student’s t test) Anti-
pSrc(Tyr416) antibody reacts with Src family kinases [71].
(DOC)
Figure S5 Overexpression of SH2B1b increases cell
migration. PC12-GFP and PC12-SH2B1b cells were differen-
tiated and subjected to wound healing as described in Figure 1.
Live cell images were taken on healing days 0 and 23 using Carl
Zeiss Observer Z1 microscope. Scale bar: 200 mm.
(DOC)
Figure S6 PMA treatment increases SH2B1b levels.
PC12-SH2B1b cells were differentiated and subjected to wound
healing protocol. On differentiation day 8, un-wounded (U) or
wounded cells were treated with or without 162 nM PMA. Cell
lysates were collected from un-wounded (U) cells and cells during
healing days 0–5. Equal amount of proteins from lysates was
resolved via SDS-PAGE and immunoblotted with anti-SH2B1
and anti-HDAC antibodies. Polyclonal antibody to rat SH2B1 was
generously provided by Dr. Christin Carter-Su at the University of
Michigan, USA.
(DOC)
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